Pharma Journalist -

The European Commission (EC) has expanded the marketing authorization for Dupixent (dupilumab) in the European Union (EU) to treat eosinophilic esophagitis (EoE) in adults and…
Read More...

Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, announced that the U.S. Food and Drug Administration…
Read More...

Rewind Therapeutics announced that it has raised additional funding, with Sunstone Life Science Ventures A/S joining as a new investor and with participation of existing investors…
Read More...

Evotec SE announced that the Company has entered into a strategic collaboration and licence agreement with Janssen Biotech, Inc. (“Janssen”), one of the Janssen Pharmaceutical Companies…
Read More...

Roche and its subsidiary TIB Molbiol have developed a COVID-19 PCR test for researchers that detects and differentiates the latest variant of concern, XBB.1.5. The XBB.1.5 variant is…
Read More...

BioArctic AB's (publ) partner Eisai announced that the European Medicines Agency (EMA) has accepted a marketing authorization application (MAA) for lecanemab, an investigational…
Read More...

CytomX Therapeutics, Inc. announced that it achieved a clinical candidate milestone under its TCB agreement with Astellas. The clinical candidate is the first Probody TCB molecule to…
Read More...

The U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for Jardiance (empagliflozin) tablets, which is being investigated as a potential…
Read More...

POXEL SA, a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic…
Read More...

Rewind Therapeutics, a company developing first-in-class treatments for demyelination-associated diseases, announced that it has raised additional funding, with Sunstone Life Science…
Read More...